Related references
Note: Only part of the references are listed.Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Senescence-associated inflammatory responses: aging and cancer perspectives
Audrey Lasry et al.
TRENDS IN IMMUNOLOGY (2015)
Resected pancreatic cancer outcomes in the elderly
Jessica M. Frakes et al.
JOURNAL OF GERIATRIC ONCOLOGY (2015)
Generalizability of Trial Results to Elderly Medicare Patients With Advanced Solid Tumors (Alliance 70802)
Elizabeth B. Lamont et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
An update on a systematic review of the use of geriatric assessment for older adults in oncology
M. T. E. Puts et al.
ANNALS OF ONCOLOGY (2014)
Adjuvant chemotherapy in elderly patients with pancreatic cancer
A. M. Nagrial et al.
BRITISH JOURNAL OF CANCER (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy
Alexandr V. Bazhin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer
Hans Wildiers et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma
Abhishek D. Parmar et al.
SURGERY (2014)
Celiac plexus neurolysis in pancreatic cancer: The endoscopic ultrasound approach
Andrada Seicean
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Celiac plexus neurolysis in the management of unresectable pancreatic cancer: When and how?
Jonathan M. Wyse et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Pancreatic cancer: Role of the immune system in cancer progression and vaccine-based immunotherapy
Amedeo Amedei et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Polypharmacy and the management of the older cancer patient
L. Balducci et al.
ANNALS OF ONCOLOGY (2013)
Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions
Amedeo Amedei et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Clinical evaluation and optimal management of cancer cachexia
Albert Tuca et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis
Wei-Chih Liao et al.
LANCET ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patients
Carolyn H. Kim et al.
RADIATION ONCOLOGY (2013)
The Effectiveness of Repeat Celiac Plexus Neurolysis for Pancreatic Cancer: A Pilot Study
Kai McGreevy et al.
PAIN PRACTICE (2013)
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
Faruk Tas et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC
Augusto Caraceni et al.
LANCET ONCOLOGY (2012)
Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm?
Kian-Huat Lim et al.
ONCOLOGIST (2012)
The Value of Geriatric Assessments in Predicting Treatment Tolerance and All-Cause Mortality in Older Patients With Cancer
Marije E. Hamaker et al.
ONCOLOGIST (2012)
Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer
Gopi K. Prithviraj et al.
JOURNAL OF GERIATRIC ONCOLOGY (2012)
Stereotactic Body Radiotherapy in the Treatment of Advanced Adenocarcinoma of the Pancreas
Jean-Claude M. Rwigema et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
ADJUVANT CHEMORADIATION THERAPY AFTER PANCREATICODUODENECTOMY IN ELDERLY PATIENTS WITH PANCREATIC ADENOCARCINOMA
David P. Horowitz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
Patrick J. Loehrer et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
Arti Hurria et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Resection Benefits Older Adults with Locoregional Pancreatic Cancer Despite Greater Short-Term Morbidity and Mortality
Taylor S. Riall et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Polypharmacy in elderly patients with cancer: clinical implications and management
Judith Lees et al.
LANCET ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The impact of surgical outcome after pancreaticoduodenectomy in elderly patients
Yasuhiro Ito et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2011)
Role of chemotherapy in the very elderly patients with metastatic pancreatic cancer - A Veterans Affairs Cancer Registry analysis
Ibrahim T. Aldoss et al.
JOURNAL OF GERIATRIC ONCOLOGY (2011)
OUTCOMES AND TOLERABILITY OF CHEMORADIATION THERAPY FOR PANCREATIC CANCER PATIENTS AGED 75 YEARS OR OLDER
David T. Miyamoto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas
Daniel T. Chang et al.
CANCER (2009)
The cancer survival gap between elderly and middle-aged patients in Europe is widening
Alberto Quaglia et al.
EUROPEAN JOURNAL OF CANCER (2009)
Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group
Elizabeth Poplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
David Cunningham et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Utilization and Determinants of Adjuvant Therapy Among Older Patients Who Receive Curative Surgery for Pancreatic Cancer
Jessica A. Davila et al.
PANCREAS (2009)
Significance of Cellular Senescence in Aging and Cancer
Angela Grimes et al.
CANCER RESEARCH AND TREATMENT (2009)
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.: Definitive results of the 2000-01 FFCD/SFRO study
B. Chauffert et al.
ANNALS OF ONCOLOGY (2008)
Cancer cachexia: Developing multimodal therapy for a multidimensional problem
K. C. H. Fearon
EUROPEAN JOURNAL OF CANCER (2008)
What constitutes a High-Volume hospital for pancreatic resection?
Robert A. Meguid et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Borderline resectable pancreatic cancer: The importance of this emerging stage of disease
Matthew H. G. Katz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
Raphael Marechal et al.
PANCREAS (2008)
The effect of age on short-term outcomes after pancreatic resection - A population-based study
Taylor S. Riall et al.
ANNALS OF SURGERY (2008)
Outcomes in octogenarians undergoing high-risk cancer operation: A national study
Emily Finlayson et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review
Suzanne M. Jeurnink et al.
BMC GASTROENTEROLOGY (2007)
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer:: A randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Richard Herrmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Older female cancer patients: Importance, causes, and consequences of undertreatment
Christine Bouchardy et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
A. Sultana et al.
BRITISH JOURNAL OF CANCER (2007)
Delayed recovery after pancreaticoduodenectomy: A major factor impairing the delivery of adjuvant therapy?
Thomas E. Aloia et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy
Gauri R. Varadhachary et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas
F Maire et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Pancreaticoduodenectomy in the very elderly
MA Makary et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
C Louvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients
C Morizane et al.
ONCOLOGY (2005)
Cancer in older persons: An international issue in an aging world
R Yancik et al.
SEMINARS IN ONCOLOGY (2004)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration
L Talarico et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Treatment of locally advanced pancreatic cancer in the real world: Population-based practices and effectiveness
MK Krzyzanowska et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer
H Shinchi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
The vulnerable elders survey: A tool for identifying vulnerable older people in the community
D Saliba et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2001)
Radical resection of periampullary tumors in the elderly: Evaluation of long-term results
OF Bathe et al.
WORLD JOURNAL OF SURGERY (2000)
Cancer and aging - An evolving panorama
L Balducci et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2000)
Share Paper
